Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Journal article
Watson JA. et al, (2024), eLife, 13
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Journal article
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Journal article
Pukrittayakamee S. et al, (2024), eLife, 12
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria-authors' response.
Journal article
Saralamba S. et al, (2024), J Antimicrob Chemother
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of phase 2 antiviral studies
Preprint
Wongnak P. et al, (2024)
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Journal article
Luvira V. et al, (2024), BMC Infectious Diseases, 24
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)
Preprint
Maitland K. et al, (2024)
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Journal article
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Journal article
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
Journal article
Watson JA. et al, (2023), PLoS Med, 20
A systematic review of neglected tropical diseases (NTDs) in Myanmar.
Journal article
Swe MMM. et al, (2023), PLoS neglected tropical diseases, 17
Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis.
Journal article
Zaw AS. et al, (2023), PLoS medicine, 20
Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study
Journal article
Fanello C. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 109, 965 - 974
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Journal article
Mehdipour P. et al, (2023), Malaria journal, 22
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Journal article
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Journal article
Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Journal article
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
Journal article
Thriemer K. et al, (2023), BMC Medical Research Methodology, 23
Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.
Journal article
Shepherd JM. et al, (2023), Intensive care medicine, 49, 922 - 933